COMP <GO>
NGVT vs NEM // EV/EBITDA & P/E VALUATION
Ingevity Corporation (NYSE) VS. Newmont Corporation (NYSE) • 15-METRIC TALLY: NGVT 4
— NEM 7
▲ EV/EBITDA & P/E VALUATION LEADER: NGVT
LAST: $75.37 (+1.62%) • MKT CAP: $2.59B
valuation
6.0x
LAST: $111.80 (-1.86%) • MKT CAP: $116.18B
valuation
11.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NGVT VS. NEM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NGVT | NEM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 21.80% | +63.20 | NGVT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 6.0x | 11.9x | -5.90 | NGVT | /valuation <GO> |
| Free Cash Flow Yield | 12.78% | 8.02% | +4.76 | NGVT | /fcf-yield <GO> |
| Operating Margin | 35.90% | 38.10% | -2.20 | NEM | /operating-margins <GO> |
| Net Profit Margin | -14.30% | 31.30% | -45.60 | NEM | /net-margins <GO> |
| Revenue Growth (YoY) | -2.70% | 21.30% | -24.00 | NEM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.95% | -0.95 | NEM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.93 | 4.16 | -1.23 | NEM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | NEM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.0 | 45.4 | +16.62 | NGVT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.04 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 13.8x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.59B | $116.18B | -$113.59B | NEM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NGVT REV | NEM REV | NGVT GROSS % | NEM GROSS % | NGVT FCF | NEM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.17B | $22.67B | 39.5% | — | $331.2M | $9.31B |
| FY 2024 | $1.20B | $18.68B | 38.7% | — | $128.6M | $5.52B |
| FY 2023 | $1.22B | $11.81B | — | — | $205.1M | $2.23B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NGVT // BETA —
NEM // BETA 1.04